Increased frequency of Tim-3 expressing T cells is associated with symptomatic West Nile virus infection

Marion C. Lanteri; Michael S. Diamond; Jacqueline P. Law; Glen M. Chew; Shiquan Wu; Heather C. Inglis; Derek Wong; Michael P. Busch; Philip J. Norris; Lishomwa C. Ndhlovu

doi:10.1371/journal.pone.0092134

Increased frequency of Tim-3 expressing T cells is associated with symptomatic West Nile virus infection

Marion C. Lanteri, Michael S. Diamond, Jacqueline P. Law, Glen M. Chew, Shiquan Wu, Heather C. Inglis, Derek Wong, Michael P. Busch, Philip J. Norris, Lishomwa C. Ndhlovu

Research output: Contribution to journal › Article › peer-review

12 Scopus citations

Abstract

More than a decade after West Nile virus (WNV) entered North America, and despite a significant increase in reported cases during the 2012 and 2013 seasons, no treatment or vaccine for humans is available. Although antiviral T cells contribute to the control of WNV, little is known about their regulation during acute infection. We analyzed the expression of Tim-3 and PD-1, two recently identified T cell negative immune checkpoint receptors, over the course of WNV infection. Symptomatic WNV⁺ donors exhibited higher frequencies of Tim-3⁺ cells than asymptomatic subjects within naïve/early differentiated CD28^+/-CD57^-CD4 ⁺ and differentiated CD28^-CD57^-CD8⁺ T cells. Our study links Tim-3-expression on T cells during acute WNV infection with the development of symptomatic disease, suggesting Tim-3 and its ligands could be targeted therapeutically to alter anti-WNV immunity and improve disease outcome.

Original language	English
Article number	e92134
Journal	PloS one
Volume	9
Issue number	3
DOIs	https://doi.org/10.1371/journal.pone.0092134
State	Published - Mar 18 2014

Access to Document

10.1371/journal.pone.0092134

Cite this

@article{a9552881837447129d6a34afe22ad072,

title = "Increased frequency of Tim-3 expressing T cells is associated with symptomatic West Nile virus infection",

abstract = "More than a decade after West Nile virus (WNV) entered North America, and despite a significant increase in reported cases during the 2012 and 2013 seasons, no treatment or vaccine for humans is available. Although antiviral T cells contribute to the control of WNV, little is known about their regulation during acute infection. We analyzed the expression of Tim-3 and PD-1, two recently identified T cell negative immune checkpoint receptors, over the course of WNV infection. Symptomatic WNV+ donors exhibited higher frequencies of Tim-3+ cells than asymptomatic subjects within na{\"i}ve/early differentiated CD28+/-CD57-CD4 + and differentiated CD28-CD57-CD8+ T cells. Our study links Tim-3-expression on T cells during acute WNV infection with the development of symptomatic disease, suggesting Tim-3 and its ligands could be targeted therapeutically to alter anti-WNV immunity and improve disease outcome.",

author = "Lanteri, {Marion C.} and Diamond, {Michael S.} and Law, {Jacqueline P.} and Chew, {Glen M.} and Shiquan Wu and Inglis, {Heather C.} and Derek Wong and Busch, {Michael P.} and Norris, {Philip J.} and Ndhlovu, {Lishomwa C.}",

year = "2014",

month = mar,

day = "18",

doi = "10.1371/journal.pone.0092134",

language = "English",

volume = "9",

journal = "PLoS ONE",

issn = "1932-6203",

number = "3",

}

TY - JOUR

T1 - Increased frequency of Tim-3 expressing T cells is associated with symptomatic West Nile virus infection

AU - Lanteri, Marion C.

AU - Diamond, Michael S.

AU - Law, Jacqueline P.

AU - Chew, Glen M.

AU - Wu, Shiquan

AU - Inglis, Heather C.

AU - Wong, Derek

AU - Busch, Michael P.

AU - Norris, Philip J.

AU - Ndhlovu, Lishomwa C.

PY - 2014/3/18

Y1 - 2014/3/18

N2 - More than a decade after West Nile virus (WNV) entered North America, and despite a significant increase in reported cases during the 2012 and 2013 seasons, no treatment or vaccine for humans is available. Although antiviral T cells contribute to the control of WNV, little is known about their regulation during acute infection. We analyzed the expression of Tim-3 and PD-1, two recently identified T cell negative immune checkpoint receptors, over the course of WNV infection. Symptomatic WNV+ donors exhibited higher frequencies of Tim-3+ cells than asymptomatic subjects within naïve/early differentiated CD28+/-CD57-CD4 + and differentiated CD28-CD57-CD8+ T cells. Our study links Tim-3-expression on T cells during acute WNV infection with the development of symptomatic disease, suggesting Tim-3 and its ligands could be targeted therapeutically to alter anti-WNV immunity and improve disease outcome.

AB - More than a decade after West Nile virus (WNV) entered North America, and despite a significant increase in reported cases during the 2012 and 2013 seasons, no treatment or vaccine for humans is available. Although antiviral T cells contribute to the control of WNV, little is known about their regulation during acute infection. We analyzed the expression of Tim-3 and PD-1, two recently identified T cell negative immune checkpoint receptors, over the course of WNV infection. Symptomatic WNV+ donors exhibited higher frequencies of Tim-3+ cells than asymptomatic subjects within naïve/early differentiated CD28+/-CD57-CD4 + and differentiated CD28-CD57-CD8+ T cells. Our study links Tim-3-expression on T cells during acute WNV infection with the development of symptomatic disease, suggesting Tim-3 and its ligands could be targeted therapeutically to alter anti-WNV immunity and improve disease outcome.

UR - http://www.scopus.com/inward/record.url?scp=84898636382&partnerID=8YFLogxK

U2 - 10.1371/journal.pone.0092134

DO - 10.1371/journal.pone.0092134

M3 - Article

C2 - 24642562

AN - SCOPUS:84898636382

VL - 9

JO - PLoS ONE

JF - PLoS ONE

SN - 1932-6203

IS - 3

M1 - e92134

ER -

Increased frequency of Tim-3 expressing T cells is associated with symptomatic West Nile virus infection

Abstract

Access to Document

Other files and links

Fingerprint

Cite this